This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Each team was selected for their solutions and ideas at the cutting edge of technology, including drug development, healthcare delivery and sustainability. Throughout the ON Accelerate program, each team was provided with the tools and resources to translate their ideas into tangible solutions and market-ready ventures.
Held in New York during March 17-20, 2025, the event focused on pharmaceutical innovation, industry outlook, capacity expansion, and supply chain resilience, driven by the increasing digitization of drug development and manufacturing. Avantor, Inc.
. – October 1, 2024 – Frost & Sullivan assessed the laboratory information management systems (LIMS) industry and, based on its findings, recognizes LabVantage Solutions with the 2024 Global Company of the Year Award. LabVantage LIMS is an enterprise platform serving the full product life cycle.
Rackspace Technology ® (NASDAQ: RXT) , a leading end-to-end hybrid, multicloud and AI technology solutions company, has announced the launch of Rackspace UK Sovereign Services as part of its next generation product set. Sovereign cloud services keep data, support, and infrastructure within the borders of a national state.
The pace of technological evolution is accelerating, reshaping industries and forcing organizations to rethink their growth strategies. From AI-driven cybersecurity to quantum sensors, energy-efficient manufacturing, and next-gen health solutions , the world is witnessing a technological revolution that demands bold investments.
Image: nuclear_lily/stock.adobe.com The threat of ransomware is a leading concern for industries globally. Specifically, conflicts in the Middle East and Eastern Europe spurred a rise in hacktivist personas employing ransomware to disrupt industrial operations.
Pharma companies are embracing innovative strategies in commercial market access, aiming to navigate regulatory bodies, healthcare providers (HCPs), and end users more efficiently. Pharma companies must maintain a competitive edge by continuously adapting to changes in market and end-user perspectives.
The demand is increasing for robotic process automation in healthcare, as robotic process automation can mimic human interaction. Healthcare providers gather huge amounts of data like personal information of the patient or the treatment cycle of the patient every day. billion in 2022 and is projected to reach $69.20 billion by 2032.
Healthcare sector enjoyed its well-deserved prominence in 2022 with all round operational efficiency, expansion, and digitization gains across pharma, medtech, and delivery. In addition to burgeoning in-house innovation, India’s G20 leadership in 2023 will open new avenues for collaborative growth in the healthcare sector.
The newly announced agenda for Connect in Pharma sends a strong message for more cross-sector collaboration. A recently released report from Connect in Pharma found that pharma lagged behind other sectors when it came to the adoption of digitally-enabled manufacturing techniques. is also due to speak at Connect in Pharma.
JAMP Pharma Group acquires the manufacturing operations of this plant at a time when governments, customers, and partners are calling for more local procurement solutions. “For several years, healthcare professionals and patients have had to deal with inventory shortages.
Group has announced the acquisition of healthcare tooling manufacturer Winther Mould Technology A/S. Both companies offer decades of experience in meeting the needs of leading healthcare customers. ” MGS is expanding global access to vertically integrated solutions, now with 1,200 employees at 12 locations across the U.S.,
Experts, including oncologists, decision-support scientists, and healthcare professionals, are currently navigating the complex process of identifying biomarker correlations based on a patient’s genetic makeup. Note: Gain valuable perspectives from these industry experts by clicking here to access the recorded session of the Think Tank.
PA Consulting and PulPac are calling upon pharma, consumer health and FMCG industries to join the Blister Pack Collective to bring the world’s first Dry Molded Fiber tablet pack to market – minimising the use of plastics for over-the-counter and prescription drugs and vitamins.
To discuss supply chain issues, recent developments, and innovations in pharmaceutical development, and manufacturing, industry participants shared their strategic viewpoints and growth strategies during DCAT 2023. Managing optimal inventory levels remains vital as CDMOs work on multiple projects simultaneously.
ProductLife Group (PLG), a global leader in regulatory, scientific, compliance, and digital transformation consulting for the life sciences industry, is pleased to announce the acquisition of HERAX Life Science, a leading Danish business and technology consultancy providing tailored services and solutions for the life sciences industry.
With a highly specialised profile, Chemspec Europe is a key event for the fine and speciality chemicals industry, taking place from 24-25 May at the Messe Basel exhibition centre in Switzerland. It operates in a rapidly changing market and faces many challenges. Free visitor registration is available on www.chemspeceurope.com.
San Antonio, TX — September 19, 2023 — Frost & Sullivan recently researched the life sciences quality management and compliance solutions and services industry and, based on its findings, recognizes Verista with the 2023 Global Customer Value Leadership Award.
Addressing Industry Challenges with AI The clinical trial industry faces several challenges, including rising competition, global disruptions, and rapid technological changes. It also facilitates collaboration between traditionally separate industries, creating new opportunities for growth and innovation.
November 30, 2022 – Recently, Frost & Sullivan analyzed the global medical device connectivity industry and, based on its research findings, recognizes S3 Connected Health with the 2022 Global Customer Value Leadership Award for medical device connectivity. SAN ANTONIO, TX.
Olivier Casamitjana, Senior Vice President and Global Compound Management Head at Evotec said: “This agreement aligns Titian as a solution provider with our plans to expand our business further, enabling easy extension of Evotec’s systems and ensuring Titian can respond dynamically to our operational needs.”
San Antonio, TX — December 8, 2022 — Based on its recent analysis of the clinical trial patient recruitment IT solutionsindustry, Frost & Sullivan recognizes TrialWire with the 2022 Global Clinical Trial Patient Recruitment IT Solutions Technology Innovation Leadership Award.
High-tech manufacturing industry examples Manufacturing becomes high-tech when businesses use sophisticated, usually computer-controlled, equipment to produce the product. Many industries using high-tech manufacturing are highly regulated to help ensure consumers can use the product safely. Regulatory oversight is intense.
The US has been India’s second largest investor since FY21; India had received 811 industrial investment proposals to the tune of $43bn up to August 2022. A diversified economy, increasing foreign investments, trade, productivity gains and the growing consumption in the domestic market could be responsible for India’s growth.
THE SOLUTION Using Leo, Feedly’s AI engine, to build a hub to monitor innovations, trends, competitors, and opportunities. Case Study. This leading logistics provider scans the horizon to identify trends and opportunities in real time. A small innovation team with a huge impact across the company.
Industry participants highlighted capability expansion, recent developments, and breakthroughs in pharmaceutical development and manufacturing to support drug development. SCHOTT Pharma announced expansion plans in the US to meet the growing demand for mRNA vaccines, GLP1 drugs, and biologics. CDMOs adopting Industry 4.0
Research should look at problems that people face and try to solve them through tools or services; support and ideas could come in the form of industry collaborations. Research-based studies need support from the government and industry. Our researchers are the country’s frontline warriors in the war against our grand problems.
Leading domestic pharma companies like Glenmark Pharma are developing and out-licensing new chemical entities (NCEs) and new biological entities (NBEs). Leading domestic pharma companies like Glenmark Pharma are developing and out-licensing new chemical entities (NCEs) and new biological entities (NBEs).
The healthcare and life sciences industry is at a pivotal moment, poised for rapid transformation driven by groundbreaking advancements in technology, digital health, and personalized medicine. Want to dive deeper into transformative trends and uncover key growth opportunities in healthcare & life sciences?
Healthcare Access As healthcare costs continue to soar, one of the most critical barriers facing patients in the U.S. Could you outline how this affects different parts of the healthcare ecosystem? Thats why our solution had to work across the boardnot just for one stakeholder. healthcare dynamics.
The pharmaceutical and biotechnology industries are at the cusp of a transformative era in 2025, driven by cutting-edge innovation, evolving regulations, and increasing market pressures. Download our full analysis on the top 6 growth opportunities in pharma and biotech. Want deeper insights?
The rapid pace of technological evolution is accelerating, reshaping industries and forcing businesses to rethink their growth strategies. From AI-driven cybersecurity to quantum sensors, energy-efficient manufacturing, and next-gen health solutions , the world is witnessing a technological revolution that demands bold investments.
The Expanding Role of Clinical Contract Peripheral Services As the pharmaceutical and biopharma industries recalibrate after the COVID-19 pandemic, clinical trial outsourcing has surged, creating significant opportunities for contract research organizations (CROs). The global CRO industry, valued at $66.39 billion by 2030.
Innovating for Growth: The Future of Biotech CROs The biotech Contract Research Organization (CRO) industry is undergoing a rapid transformation, driven by technological advancements, globalization, and evolving patient needs. Lets begin by discussing the transformative trends shaping the biotech Contract Research Organization(CRO) industry.
The convergence of artificial intelligence (AI), sustainability, and advanced materials is reshaping industries, unlocking billion-dollar opportunities across healthcare, energy, and digital transformation. Industry Expansion: Projected to exceed $400 billion by 2029 , driven by cardiovascular health and obesity treatments.
Understanding the Next Era of Pharmaceutical Logistics The pharmaceutical industry is undergoing unprecedented transformation as global disruptions, regulatory complexities, and rising healthcare demands reshape supply chain strategies. billion by 2027 , real-time monitoring is no longer a luxuryits a necessity.
The 43rd JP Morgan Healthcare Conference , held from January 1316, 2025, in San Francisco, brought together a vibrant ecosystem of global pharma stakeholders, innovative startups, emerging biotech companies, and investors. Key Examples : Johnson & Johnson announced the acquisition of Intra-Cellular Therapies, Inc.
The global healthcareindustry is set to surpass $3 trillion by 2025, fueled by advancements in pharmaceuticals, diagnostics, medical technology, and digital health. With digital health expected to grow at a 13% CAGRreaching over $750 billion by 2028telemedicine, wearables, and remote monitoring are transforming healthcare delivery.
We organize all of the trending information in your field so you don't have to. Join 45,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content